Product
Supplier
Encyclopedia
Inquiry
Home > Biochemical Engineering > Polypeptide > Orforglipron for Sale > Orforglipron peptide API
Orforglipron peptide API buy - large image1
Orforglipron peptide API buy - image1
Orforglipron peptide API buy - image2
Orforglipron peptide API buy - image3
Orforglipron peptide API buy - image4
Orforglipron peptide API buy - image5

Orforglipron peptide API

GMP 29 Inquiries

Unit Price: Get Latest Price
CAS No.:

2212020-52-3

Grade:

Pharmaceutical Grade

Content:

98%

Port:

Hangzhou

Brand:

Thinheal Pharma

Packaging:

5g 50g 1kg

Price valid (until):

2026-07-11

Company Type:
Manufactory
Location:
China
Qualification:
Main Products:

Semaglutide,Retatrutide,Tirzepatide,Linaclotide

  • Product Description

  • Seller Information

  • Inquiry History

  • Description


    1. Product Overview

    Orforglipron (CAS 2212020-52-3, also known as LY3502970) is a novel, orally available small molecule compound developed for research and pharmaceutical development purposes. It is widely studied in the field of receptor biology and metabolic mechanism research, serving as a key intermediate and research tool for related preclinical and analytical studies.

    2. Basic Information

    • Chemical Name: Orforglipron
    • CAS No.: 2212020-52-3
    • Molecular Formula: C₄₈H₄₈F₂N₁₀O₅
    • Molecular Weight: 882.97 g/mol
    • Appearance: White to light yellow solid powder
    • Purity: ≥98.0% (determined by HPLC)
    • Solubility: Soluble in common organic solvents
    • Storage Condition: Store at -20°C in a dry, dark place, avoid repeated freeze-thaw cycles

    3. Applications

    • Used as a core research compound in GLP-1 receptor biology and related mechanism studies.
    • Applied in pharmaceutical R&D as an intermediate for exploring oral small-molecule candidates in metabolic research.
    • Served as a reference standard and analytical tool in preclinical studies and method development.

    4. Specifications


    Item Specification
    Appearance White to light yellow solid powder
    Purity (HPLC) ≥98.0%
    Water Content ≤0.5%
    Residue on Ignition ≤0.5%
    Heavy Metals ≤10 ppm
    Related Substances ≤2.0%

    5. Quality Control

    Our Orforglipron is produced under strict quality management systems. Each batch is tested by HPLC for purity, along with comprehensive analyses including moisture, residual solvents, and heavy metals. A detailed Certificate of Analysis (COA) is provided with every shipment to ensure consistent quality and traceability.

    6. Packaging & Delivery

    • Standard Packaging: 1kg per aluminum foil bag; 5kg/10kg/25kg per fiber drum, or customized according to customer requirements.
    • Shipping: Samples are available upon request. Bulk orders can be delivered via air or sea freight, with cold chain options for temperature-sensitive products.
    • Lead Time: 7–15 working days after order confirmation, subject to order quantity and customization needs.

    Shop Orforglipron-Detailed Image 1

    Shop Orforglipron-Detailed Image 2
    Shop Orforglipron-Detailed Image 3

    Certificates

    Basic Info
    Product Name:

    Orforglipron

    Other Name:

    1,2,4-Oxadiazol-5(2H)-one, 3-[(1S,2S)-1-[2-[[(4S)-2-(4-fluoro-3,5-dimethylphenyl)-3-[3-(4-fluoro-1-methyl-1H-indazol-5-yl)-2,3-dihydro-2-oxo-1H-imidazol-1-yl]-2,4,6,7-tetrahydro-4-methyl-5H-pyrazolo[4,3-c]pyridin-5-yl]carbonyl]-5-[(4S)-tetrahydro-2,2-dimethyl-2H-pyran-4-yl]-1H-indol-1-yl]-2-methylcy...;LY3502970;GLP-1 receptor agonist 1 USP/EP/BP;Orforglipron;Orforglipron(LY3502970);LY3502970 (Orforglipron);3-((1S,2S)-1-(5-((S)-2,2-dimethyltetrahydro-2H-pyran-4-yl)-2-((S)-3-(3-(4-fluoro-1-methyl-1H-indazol-5-yl)-2-oxo-2,3-dihydro-1H-imidazol-1-yl)-2-(4-fluoro-3,5-dimethylphenyl)-4-methyl-4,5,6,7-tetrahydro-2H-pyrazolo[4,3-c]pyridine-5-carbonyl)-1H-indol-1-yl)-2-methylcyclopropyl)-1,2,4-oxadiazol-5(4H)-one;OWL 833

    CAS No.:

    2212020-52-3

    Molecular Formula:

    C48H48F2N10O5

    InChIKeys:

    USUWIEBBBWHKNI-BBGRWQLENA-N

    Molecular Weight:

    882.97

    EC Number:

    278-636-5

    Color/Form:

    Off-white to light yellow

    Categories:

    Polypeptide

    Characteristics
    Density:

    1.50±0.1 g/cm3(Predicted)

    PKA:

    7.33±0.20(Predicted)

    Critical Temperature & Pressure:

    Store at -20°C

  • Seller Information
    Business Type:

    Manufactory

    Main Products:

    Semaglutide,Retatrutide,Tirzepatide,Linaclotide

    Location:

    8th Floor, Building 2, Phase 5, Xiasha Heda Pharmaceutical Valley, Qiantang District, Hangzhou, Zhejiang Province

    Payment Terms:

    TT against copy of documents

    Average lead Time:

    7

    Total Annual Revenue:

    $25 million-$50 million

    Total Employees:

    301-500

    Year of Establishment:

    2019

    Certifications:

    WC,GMP

    杭州信海医药科技有限公司成立于2019年,是一家专注于多肽产品的研发、生产、销售与定制、研发生产相结合的生物医药企业。核心管理团

    队由具有深厚医药专业背景的专业人士组成。信海医药建有一个研发中心和两个生产基地,目前化学合成多肽总产能已达数吨级规模。


         公司具备完整高效的多肽研发、生产及销售体系,提供全方位的多肽产业化服务,包括原料药研发和生产业务、制剂研发业务、多肽定制研发生产(CDMO)业务、以及美容肽研发生产业务。现阶段产品主要包括司美格鲁肽、替尔泊肽、利那洛肽、瑞塔鲁肽等数十个品种,其中司美格鲁肽、替尔泊肽、利那洛肽等多个品种已完成美国FDA DMF备案。

         公司以固、液相结合的化学合成工艺手段为驱动,建有复杂多肽及类肽化学合成及修饰平台、多肽片段设计与合成技术平台、多分离手段纯化平台等完善研发体系,拥有一支130人以上研发队伍,博士、硕士学历人员占比近20%,核心研发团队拥有超过20年的多肽药物开发经验,具备深厚的专业背景和丰富的实践经验.

  • Inquiry History
    29 Inquiries
    Country Product Purchase Quantity Date Posted
    Bulgaria

    orforglipron

    1 KG Aug 27, 2025
    Austria

    Orforglipron

    1000 MT Jun 12, 2026
    Switzerland

    Orforglipron

    10 MG Apr 25, 2026
    United States

    Orforglipron

    20 G Apr 3, 2026
    United States

    Orforglipron

    10 G Mar 29, 2026
    United States

    oforglipron

    3 KG Jul 4, 2025
    India

    orforglipron

    1.00 G Jul 16, 2026
    United States

    Orforglipron

    200 PCS Jun 18, 2026
    United States

    orforglipron

    10 G Apr 20, 2026
    United States

    Orforglipron

    10 G Apr 6, 2026
    United States

    orforglipron

    1 G Mar 24, 2026
    Germany

    Orforglipron

    2 G Mar 23, 2026
    Bangladesh

    Orforglipron

    500.00 KG Mar 9, 2026
    United States

    Orforglipron

    10 G Feb 28, 2026
    United Kingdom

    Orforglpron

    50 G Feb 12, 2026
    United States

    orforglipron

    1 KG Feb 6, 2026
    Lithuania

    Orforglipron

    6 G Jan 23, 2026
    China

    Orforglipron

    50 KG Nov 10, 2025
    United Kingdom

    Orforglipron

    1 G Jul 9, 2026
    United States

    Orforglipron

    1 G Jun 23, 2026
    • 1
    • 2
    • Go to Page Go
    Post an enquiry for this product
pic ×

Scan the QR Code to Share

All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.

According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.

The information shown above is provided by the enterprise itself, and the authenticity, accuracy and legitimacy of the content are the responsibility of the publishing company. ECHEMI does not bear any guarantee responsibility for this. Please be aware that risks in internet transactions objectively exist.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.